Some volunteers have quit Johnson & Johnson's COVID-19 vaccine trial in Spain after news of side effects in a participant in AstraZeneca's trial, the Spanish programme's lead investigator told Reuters on Tuesday.
"Many have called to ask us some more detail about the risk of the vaccine, whether what happened with that vaccine had anything to do with the one we are studying, these types of questions", Borobia said.
Together with the AstraZeneca vaccine, it is on the list of WHO-monitored list of candidate vaccines on a quest to get approved for industrial production once they complete all three required phases of clinical trials.
Last week, Oxford temporarily paused its large-scale vaccination tests after one participant in the United Kingdom reported severe neurological symptoms; it was restarted on Sunday. Governments and citizens across the world were pinning big hopes on the inoculation seen as a viable shot against SARS-CoV-2, the virus that causes COVID-19. The vaccine's development process has been criticized by some Western countries for its supposedly unsafe rapid development and improper testing.
One part of the phase 1 clinical trials kicked off on September 1 in East China's Jiangsu province, and Hong Kong trials are expected to begin in November, local media reported.
Phase III clinical trials of Russia's Sputnik V vaccine against COVID-19 will be conducted in the Brazilian states of Bahia and Parana, which has plans to produce the vaccine for Brazil and other Latin American countries.
U.S. puts block on Chinese products from Uighur 'forced labour'
The US Customs and Border Protection (CBP) had earlier issued five Withhold Release Orders (WRO) to uphold the ban. The WROs prevent goods from being imported into the U.S. when there are accusations of forced labour.
A viable vaccine to the coronavirus responsible for the COVID-19 illness won't be available to immunize the general public until the end of 2024, said the chief executive of the world's largest vaccine manufacturer in an exclusive interview with the Financial Times.
The Serum Institute - located in Pune - has partnered with five other pharmaceutical companies globally, including Novavax and AstraZeneca. "And then, of course, it is the regulator's job to issue a license or not".
It's not uncommon for clinical trials to be paused.
While authorities would like to inoculate the entire population of 52 million, uncertainty around any vaccine's safety, efficacy and development was limiting South Korea's investment, Mr Chung told a cabinet meeting.
Poonawalla's remarks came a day after Union health minister Harsh Vardhan said a vaccine against the coronavirus disease would be ready by early next year.